Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Ball

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Haematologica|May 25, 2010
Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesisSumin Koo, Brian J Huntly, Yuan Wang, et al.
British Journal of Haematology|December 21, 2021
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemiaAmandeep Salhotra, Ni-Chun Tsai, Jianying Zhang, et al.
American Journal of Hematology|February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemiaHoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
Research Square|November 1, 2024
Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AMLBrian Ball, Wenbin Xiao, Gautam Borthakur, et al.
Blood|December 9, 2022
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemiaAmanda Przespolewski, Aaron D Goldberg, Chetasi Talati, et al.
Blood|January 14, 2009
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation modelsMelanie G Cornejo, Michael G Kharas, Miriam B Werneck, et al.
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
British Journal of Haematology|September 1, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemiaHoda Pourhassan, Jose Tinajero, Huiyan Ma, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Haematologica|May 25, 2010
Cdx4 is dispensable for murine adult hematopoietic stem cells but promotes MLL-AF9-mediated leukemogenesisSumin Koo, Brian J Huntly, Yuan Wang, et al.
British Journal of Haematology|December 21, 2021
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemiaAmandeep Salhotra, Ni-Chun Tsai, Jianying Zhang, et al.
American Journal of Hematology|February 8, 2022
High prevalence and inferior long-term outcomes for TP53 mutations in therapy-related acute lymphoblastic leukemiaHoda Pourhassan, Dongyun Yang, Michelle Afkhami, et al.
Research Square|November 1, 2024
Phase I First-in-Human Dose Escalation Study of the oral Casein Kinase 1α and Cyclin Dependent Kinase 7/9 inhibitor BTX-A51 in advanced MDS and AMLBrian Ball, Wenbin Xiao, Gautam Borthakur, et al.
Blood|December 9, 2022
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemiaAmanda Przespolewski, Aaron D Goldberg, Chetasi Talati, et al.
Blood|January 14, 2009
Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation modelsMelanie G Cornejo, Michael G Kharas, Miriam B Werneck, et al.
Cancer Cell|June 15, 2010
Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cellsAnn Mullally, Steven W Lane, Brian Ball, et al.
British Journal of Haematology|September 1, 2025
The efficacy of targeted and immune-based therapies in adults with TP53-mutated acute lymphoblastic leukaemiaHoda Pourhassan, Jose Tinajero, Huiyan Ma, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
Cancer|October 11, 2021
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemiaIbrahim Aldoss, Salman Otoukesh, Jianying Zhang, et al.
Pageof 6